Genentech’s Actemra reduces need for ventilation in COVID-19 patients; fails to achieve secondary endpoints
Genentech’s Actemra reduces need for ventilation in COVID-19 patients; fails to achieve secondary endpoints
SeekingAlpha
0 shares
1 views